Luis Lara-Mejía, Medical Oncologist Specialized in Thoracic Neoplasms at National Institute of Cancerology, posted on X:
“Oncogenic fusions represent a diagnostic challenge across solid tumors.
This excellent review discusses the evolution of molecular platforms, pitfalls of current assays, and the future of fusion detection for precision oncology.
A must-read for molecular pathologists and oncologists.”
“Oncogenic gene fusions in cancer: from biology to therapy.”
Authors: Stephen V. Liu, Misako Nagasaka, Judith Atz, Flavio Solca and Leonhard Müllauer
